Search
04/05/2026
Pharmacogenomics of anti-seizure medications in epilepsy: a systematic review of genetic predictors of response and tolerance
Barguilla, A, Riera, P, Ros-Castelló, V, Muino, E, Sierra-Marcos, A. Pharmacogenomics of anti-seizure medications in epilepsy: a systematic review of genetic predictors of response and tolerance. Expert Review of Neurotherapeutics. 2026; 26(5)DOI:10.1080/14737175.2026.2647028. PMID:41875007. IF:3.400(Q2/3D).
04/05/2026
ARIAN protocol: a phase III study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancer
Provencio, M, Aguiar, D, Antoñanzas, M, Areses, MC, Azkárate, A, Barba, A, Bernabé, R, Blanco, R, Borregón, M, Campos, B, Coves, J, de Castro, J, Domènech, M, Dómine, M, Campelo, RG, Lucía-Gozálvez, C, Lázaro-Quintela, M, Insa, A, Juan-Vidal, O, Castro, RL, Martínez-Marti, A, Medina, S, Moreno, MA, Nadal, E, Olivares-Hernández, A, Reguart, N, Sala, MA, Medina, K, Vila, L, Massutí, B. ARIAN protocol: a phase III study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancer. EXPERT OPINION ON BIOLOGICAL THERAPY. 2026; 26(5)DOI:10.1080/14712598.2026.2677905. PMID:42159280. IF:4.000(Q2/3D).
04/05/2026
Phenotypic clustering of newly diagnosed type 2 diabetes in a Mediterranean cohort
Fernandez-Camins, B, Vlacho, B, Rojo-López, MI, Granado-Casas, M, Gratacòs, M, Ortega-Bravo, M, Cendros-Massioui, M, Palmieri, F, Perera-LLuna, A, Franch-Nadal, J, Mauricio, D. Phenotypic clustering of newly diagnosed type 2 diabetes in a Mediterranean cohort. Cardiovascular Diabetology. 2026; 25(1)DOI:10.1186/s12933-026-03198-w. PMID:42083025. IF:10.600(Q1/1D).
03/05/2026
Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer
Cella, L, Finocchiaro, A, Slusarczyk, A, Krajewski, W, Velasco, JC, Subiela, JD, Claps, F, Grobet-Jeandin, E, Del Giudice, F, Gallioli, A, Laukhtina, E, Marcq, G, Mari, A, Afferi, L, Albisinni, S, Soria, F, Hurle, R, Paciotti, M, Ferro, M, Perdonà, S, Mertens, LS, Moschini, M, Pradere, B, Contieri, R. Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer. Future Oncology. 2026; 22(11)DOI:10.1080/14796694.2026.2661768. PMID:42041162. IF:2.600(Q3/6D).
02/05/2026
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium
Baldi, GG, Giani, C, Ljevar, S, Denu, RA, Napolitano, A, Han, I, Brunello, A, Bhadri, V, Sebio, A, Andelkovic, V, Campos, F, Scanferla, R, Abreu, MH, Desar, IME, Ogura, K, Wong, DD, Bae, S, Bakhshi, S, Lefler, DS, Marquina, G, Mazzocca, A, Nakazawa, MS, Thway, K, Kim, HS, Chiusole, B, Connolly, EA, Terés, R, Antonescu, C, Bellan, E, Bovee, JVMG, Davis, JL, Tos, APD, Di Blasi, E, Lazar, AJ, Sbaraglia, M, Schaefer, IM, Taverna, S, Gronchi, A, Miceli, R, Chen, TW, Stacchiotti, S. Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium. EUROPEAN JOURNAL OF CANCER. 2026; 238DOI:10.1016/j.ejca.2026.116666. PMID:41819027. IF:7.100(Q1/2D).
01/05/2026
Biosynthetic Prosthesis Omniflow II in Chronic-Limb Threatening Ischemia: Results of the Multicenter National Registry Omni-Femoropopliteal
Baturone, A, Serrano, FJ, Camblor, LA, Alonso, M, García, F, Rodríguez, M, Marquina, R, Egaña, JM, Lozano, C, Landaluce, M, Garzón, N, Miralles, M, Fité, J, Escudero, JR, Olmos, D, Gomez-Palonés, F, Ligero, JM, Martín, A. Biosynthetic Prosthesis Omniflow II in Chronic-Limb Threatening Ischemia: Results of the Multicenter National Registry Omni-Femoropopliteal. ANNALS OF VASCULAR SURGERY. 2026; 126DOI:10.1016/j.avsg.2025.12.037. PMID:41544849. IF:1.600(Q2/5D).